The disease of the candidates was not adequately described, relying on low core (6–8) biopsy and color Doppler scans with no criteria regarding PSA, clinical stage, or Gleason score. Performing a hemiablation, the mean follow-up time was 70 months with a bDFS of 92.9% by ASTRO criteria. In addition to a strong bDFS, 88.9% retained potency preserved and 100% retained continence.

Lambert and associates released clinical trial data of unilateral cryoablation of unilateral lesions in 25 patients with a mean follow-up of 28 months.17 Inhibitors,research,lifescience,medical This study underlines the contralateral nature of PCa and the promising oncologic outcomes of retreatment with focal cryoablation. Inhibitors,research,lifescience,medical Lambert and colleagues conducted a retrospective study that monitored Gleason 6 or 7 (3 + 4) patients who had not previously received hormonal therapy or radiotherapy, with cancer confirmed to one lobe and tumor volume representing < 10% in a 12-core biopsy. Patients had a bDFS of 88%, with two patients demonstrating cancer on the contralateral side who

were retreated to focal cryoablation and Inhibitors,research,lifescience,medical considered disease free. Continence was preserved in 100% of patients and potency was preserved in 70.4%. In an effort to address the contralateral nature of PCa, Ellis and colleagues performed a trial series using a posterior hockey-stick cryoablation template.18 This study had the most vague candidate selection criteria and no biopsy mapping and as such demonstrated a high percentage of failure with contralateral lesions. Candidates were enrolled with a clinical stage between Inhibitors,research,lifescience,medical T1 to T3N0M0 and if (1) they were relatively young and unwilling to risk potency, or (2) they were older and uncomfortable with AS. The bDFS determined by PSA nadir was 88% in a study of 60 patients with a mean follow-up time of 15.2 months. Fourteen patients had positive biopsies for PCa after the procedure, 13 of which were present on the untreated side. Potency was maintained in 70.6% of patients after penile rehabilitation

and continence was maintained in 96.3%. In contrast to Inhibitors,research,lifescience,medical the Ellis and colleagues’ hockey-stick template, Onik and associates performed a 54-patient series with true focal cryoablation of a unifocal lesion.19 Although isothipendyl Onik and associates had loose enrollment criteria, the effort of using an ultrasound-guided biopsy to confirm unilateral cancer and a longer follow-up see more showed the potential success of true unifocal therapy and raised questions about the amount of prostate tissue that actually needs to be removed to obtain cancer control. Candidates were selected when an ultrasound-guided biopsy showed unilateral cancer and maintenance of potency/continence was important to the patient. With a mean follow-up of 4.5 years, the study showed 95% bDFS by ASTRO criteria, potency preservation in 90% of patients, and continence preservation in 100% of patients.